JPRN-UMIN000004468已完成1 期
Phase I/II study of gemcitabine/cisplatin/S-1(GCS) combination therapy for patients with advanced biliary tract cancer - gemcitabine/cisplatin/S-1(GCS) combination therapy for patients with advanced biliary tract cancer
Kansai Hepatobiliary Oncology Group0 个研究点目标入组 55 人开始时间: 2010年11月14日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with interstitial pneumonia or pulmonary fibrosis 2. Patients with uncontrollable diabetes mellitus, liver disease, angina pectoris or a new onset of myocardial infarction within 3 months 3. Patients with severe active infection 4. Patients who are pregnant or lactating, or have an intention to get pregnant 5. Patients with a history of severe drug allergy 6. Patients with other serious comorbid disease 7. Patients with mental disease 8. Patients who are judged inappropriate for the entry into the study by the principle doctor 9. Patients with watery diarrhea
研究者
相似试验
尚未招募
Unknown
Phase III study of gemcitabine, cisplatin plus S-1 combination therapy versus gemcitabine, cisplatin plus immune checkpoint inhibitor combination therapy in advanced biliary tract cancer.advanced biliary tract cancerJPRN-UMIN000051689Yamaguchi University460
进行中（未招募）
不适用
A Phase 1b/2 Study of Gemcitabine-Cisplatin, With or Without LY2275796 Sodium, in Patients with Advanced Stage IIIB or IV Non-Small Cell Lung Cancer - N/AEUCTR2008-001535-35-FREli Lilly and Company175
招募中
1 期
Phase 1 study of Gemcitabine, Cisplatin and S-1 combination chemotherapy in patients with advanced biliary tract cancerJPRN-UMIN000009536Kitasato University School of Medicine Department of Gastroenterology Medicine12
已完成
1 期
Phase I study of Gemcitabine, Cisplatin and S-1 for advanced biliary tract cancer.Biliary tract cancerJPRN-UMIN000006123Tsukuba University Hospital, Division of Gastroenterology12
招募中
1 期
Phase I/II study of Gemcitabine and S-1 (GS therapy) as Neoadjuvant chemoradiationtherapy for borderline resectable pancreatic cancer (Prep-03/NS014-1)Borderline resectable pancreatic cancerJPRN-UMIN000014498Study group of preoperative therapy for pancreatic cancer (PREP)40